Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Provider beliefs associated with cervical cancer screening interval recommendations: A pilot study in Federally Qualified Health Centers☆
Filetype[PDF-689.88 KB]


Details:
  • Alternative Title:
    Prev Med Rep
  • Personal Author:
  • Description:
    Background

    Among providers who serve low-income and uninsured women, resistance to extending the cervical cancer screening interval following normal Pap and co-test results has been documented. Our objective was to examine provider characteristics and beliefs associated with guideline-consistent screening interval recommendations.

    Method

    We collected cross-sectional survey data between 2009 and 2010 from 82 primary care providers in six Federally Qualified Health Centers in Illinois, USA. The relationships between characteristics, beliefs, and screening interval recommendations (1 year vs. 3 years) were tested with Pearson chi-square, negative binomial and ordered logistic regression.

    Results

    Compared to providers who recommended annual intervals after a normal co-test, providers who recommended a guideline-consistent (i.e., 3 years) screening interval were significantly more likely to report the goodness, ease, and benefit of their recommendation and perceived encouragement for a 3-year interval from professional organizations and journals (p < .05). Providers who recommended a 3-year interval were also less likely to report that longer intervals increase patient risk for cervical cancer (p < .05). Interval recommendations were not associated with provider specialty, gender, or years in practice.

    Conclusion

    Messages that promote the benefits of longer screening intervals after a normal co-test, the natural history of human papillomavirus and cervical cancer, and low risk of developing cancer with a longer interval may be useful to promote evidence-based screening in this population of Federally Qualified Health Center providers. Dissemination of targeted messages through professional journals and specialty organizations should be considered.

  • Subject:
  • Pubmed ID:
    26203428
  • Pubmed Central ID:
    PMC4508246
  • Document Type:
    Journal Article
  • Funding:
    FSX3/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers
    Personal Author:
    Roland, Katherine B.; Benard, Vicki B.; Greek, April; Hawkins, Nikki A.; Saraiya, Mona;
    Published Date:
    Aug 12 2014
    Source:
    Vaccine. 32(42):5432-5435.
    Description:
    IntroductionIn the United States, Federally Qualified Health Centers (FQHCs) are safety-net clinics that provide cervical cancer screening and human papillomavirus (HPV) vaccination to medically underserved women, some of whom may be at risk for deve...
    File Type:
    Filetype[PDF - 165.29 KB]
  2. Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers☆,☆☆
    Personal Author:
    Hawkins, Nikki A.; Benard, Vicki B.; Greek, April; Roland, Katherine B.; Manninen, Diane; Saraiya, Mona;
    Published Date:
    Sep 05 2013
    Source:
    Prev Med. 57(5):641-645.
    Description:
    ObjectiveDespite guidelines recommending cervical cancer screening intervals be extended beyond one year, clinical practice has been slow to change. Patient preferences are a potential barrier. In the Centers for Disease Control's Cervical Cancer (Cx...
    File Type:
    Filetype[PDF - 1.07 MB]
  3. Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers
    Personal Author:
    Roland, K.B.; Benard, V.B.; Greek, A.; Hawkins, N.A.; Manninen, D.; Saraiya, M.;
    Published Date:
    Apr 28 2013
    Source:
    Prev Med. 57(5):419-425.
    Description:
    ObjectiveCervical cancer screening using the human papillomavirus (HPV) test and Pap test together (co-testing) is an option for average-risk women ≥30 years of age. With normal co-test results, screening intervals can be extended. The study object...
    File Type:
    Filetype[PDF - 932.77 KB]
  4. Communication practices about HPV testing among providers in Federally Qualified Health Centers
    Personal Author:
    Lin, Lavinia; Benard, Vicki B.; Greek, April; Roland, Katherine B.; Hawkins, Nikki A.; Saraiya, Mona;
    Published Date:
    2015
    Source:
    Prev Med Rep. 2015; 2:436-439.
    Description:
    ObjectiveLittle is known about the information providers share with patients when ordering a co-test, or combined human papillomavirus (HPV) and Papanicolaou (Pap) test, for cervical cancer screening. We assessed provider perceptions of such communic...
    File Type:
    Filetype[PDF - 277.69 KB]
  5. Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening
    Personal Author:
    Benard, Vicki B.; Saraiya, Mona; Greek, April; Hawkins, Nikki A.; Roland, Katherine B.; Manninen, Diane; Ekwueme, Donatus U.; Miller, Jacqueline W.; Unger, Elizabeth R.;
    Published Date:
    December 31 2013
    Source:
    J Womens Health (Larchmt). 23(3):197-203
    Description:
    BackgroundThe recommended screening interval when using the Papanicolaou (Pap) and human papillomavirus (HPV) test (co-testing) is 5 years. However because providers are reluctant to extend the screening interval, we launched a study to identify barr...
    File Type:
    Filetype[PDF - 158.33 KB]